John Simmons

John Simmons

Company: Natera

Job title: Global Vice President, Biopharma


Identifying High-Risk Populations for Adjuvant Trials Using ctDNA MRD 11:45 am

• Use of molecular residual disease (MRD) for patient stratification or enrichment • How real-world data can inform clinical feasibility assessments and clinical trial design • How monitoring of on-treatment ctDNA dynamics and supports early prediction of therapy efficacyRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.